348622-95-7

Upstream product

• 348622-94-6 3-(diethoxyphosphoryl)succinic acid 1-tert-butyl ester 
• 104-53-0 3-phenyl-propionaldehyde 
• 5292-43-3 bromoacetic acid tert-butyl ester 

Downstream Products

• 348622-97-9 (R)-2-[2-(tert-Butoxy)-2-oxoethyl]-5-phenylpentanoic acid cyclohexylamine salt 
• 156109-64-7 (2R)-2-[2-(tert-butoxy)-2-oxoethyl]-5-phenylpentanoic acid 

Relevant academic research and scientific papers

3-heterocyclylpropanohydroxamic acid PCP inhibitors

Compounds of formula (I): and their salts, solvates, hydrates and prodrugs are useful PCP inhibitors, processes for making the same, compositions comprising the same, and methods of treating a PCP-mediated condition or disease using the same.

Novel olefination process to itaconate and succinate derivatives

An efficient and selective process, capable of scale-up, to make itaconate derivatives of formula (IV), and/or succinate derivatives of formula (V) and/or (VI) by asymmetric hydrogenation of the itaconate derivatives.

3-ox(adi) azolylpropanohydroxamic acids useful as procollagen C- Proteinase inhibitors

Compounds of formula (I): wherein the substituents are as defined herein, and their salt, solvates, and prodrugs are procollagen C-proteinase (PCP) inhibitors useful in treating conditions mediated by PCP.

PROCOLLAGEN C-PROTEINASE INHIBITORS

and their salts, solvates, prodrugs, etc., wherein the substituents have the values mentioned herein, are Procollagen C-Proteinase (PCP) inhibitors and have utility in conditions mediated by PCP.